CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Bliss GVS Pharma Ltd.

NSE : BLISSGVSEQ BSE : 506197 ISIN CODE : INE416D01022Industry : Pharmaceuticals

News

  • Bliss GVS Pharma - Board Meeting Intimation for Approval Of Audited (Standalone & Consolidated) Financial Results Of The Comp 05 May 2026 | 18:20 | Dion Global

    Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 inter alia to consider and ...more...

  • Bliss GVS Pharma has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026 17 Apr 2026 | 16:50 | Dion Global

    As of March 2026 35.36% is owned by Indian Promoters and 64.64% by Public. Institutional holds 15.49% (Insurance Companies 4.33%) and Non-In...more...

  • Bliss GVS Pharma - Copy of Newspaper Publication 10 Apr 2026 | 16:07 | Dion Global

    Bliss GVS Pharma Limited has informed the Exchange about Copy of the newspaper publication regarding the dispatch of the Postal Ballot Notice and E-v...more...

  • Bliss GVS Pharma - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 09 Apr 2026 | 17:22 | Dion Global

    Please find enclosed herewith the Postal Ballot Notice regarding the appointment of an Independent Director of the Company.more...

  • Bliss GVS Pharma - Shareholders meeting 09 Apr 2026 | 17:17 | Dion Global

    Bliss GVS Pharma Limited has informed the Exchange regarding Notice of Postal Ballot regrading appointment of Independent Directors of the Company.more...

  • Bliss GVS Pharma - Announcement under Regulation 30 (LODR)-Credit Rating 08 Apr 2026 | 16:20 | Dion Global

    Please find enclosed herewith the Intimation regarding the Credit Rating received by the Company from Investment Information and Credit Rati...more...

  • Bliss GVS Pharma - Credit Rating- New 08 Apr 2026 | 16:11 | Dion Global

    Bliss GVS Pharma Limited has informed the Exchange about Credit Rating- New rating received from ICRA Limitedmore...

  • Bliss GVS Pharma - Copy of Newspaper Publication 06 Apr 2026 | 17:22 | Dion Global

    Bliss GVS Pharma Limited has informed the Exchange about Copy of Newspaper Publicationmore...

  • Bliss GVS Pharma - Announcement under Regulation 30 (LODR)-Change in Directorate 03 Apr 2026 | 18:58 | Dion Global

    We would like to inform you that based on the recommendation of the Nomination and Remuneration Committee the Board of Directors of the Company has a...more...

  • Bliss GVS Pharma - Outcome Of The Circular Resolution Passed By The Board Of Directors 03 Apr 2026 | 18:55 | Dion Global

    We would like to inform you that based on the recommendation of the Nomination and Remuneration Committee the Board of Directors of the Comp...more...

  • Bliss GVS Pharma - Appointment 03 Apr 2026 | 18:42 | Dion Global

    Bliss GVS Pharma Limited has informed the Exchange regarding Appointment of Mr Mr. Vijayanarayanan Mahadevan as Non- Executive Independent Director o...more...

  • Bliss GVS Pharma - Outcome of Board Meeting 03 Apr 2026 | 18:38 | Dion Global

    We would like to inform you that based on the recommendation of the Nomination and Remuneration Committee the Board of Directors of the Comp...more...

  • Bliss GVS Pharma - Certificate under SEBI (Depositories and Participants) Regulations, 2018 02 Apr 2026 | 18:40 | Dion Global

    Bliss GVS Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...

  • Bliss GVS Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 02 Apr 2026 | 18:33 | Dion Global

    Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended March 31 2026.more...

  • Bliss GVS Pharma - General Updates 17 Feb 2026 | 19:49 | Dion Global

    Bliss GVS Pharma Limited has informed the Exchange about the communication to the shareholders regarding tax deduction on the interim dividend declar...more...

  • Bliss GVS Pharma - Communication To The Shareholders Regarding Tax Deduction On Interim Dividend Declared On February 10, 202 17 Feb 2026 | 19:43 | Dion Global

    Please find enclosed herewith the communication to the shareholders regarding tax deduction on the interim dividend declared on February 10 2026.more...

  • Bliss GVS Pharma - Rumour verification - Regulation 30(11) 13 Feb 2026 | 11:28 | Dion Global

    The Company wishes to clarify the news item that appeared in CNBC Awaaz today i.e. February 13 2026. Please find attached herewith Clarification Lett...more...

  • Bliss GVS Pharma - Rumour Verification - Regulation 30(11) 13 Feb 2026 | 11:23 | Dion Global

    Bliss GVS Pharma Limited has informed the Exchange about Rumour Verification - Regulation 30(11)more...

  • Bliss GVS Pharma - Clarification On News Item Appearing In 'CNBC ?????' On February 13, 2026 13 Feb 2026 | 11:12 | Dion Global

    The Company wishes to clarify the news item that appeared in CNBC Awaaz today i.e. February 13 2026. Please find attached herewith the Clarification ...more...

  • Bliss GVS Pharma - Copy of Newspaper Publication 12 Feb 2026 | 19:18 | Dion Global

    Bliss GVS Pharma Limited has informed the Exchange about Copy of Newspaper Publicationmore...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex77844.52-0.15%
NSE Index24326.65-0.01%
B500DIVL503669.34-0.12%
BSE 1000 10830.90.41%
BSE 100LCTMC9145.540.04%
BSE Auto 60131.581.81%

Commodity

Gold1506800.21%
Silver2549732.28%
Copper1307.5220.62%
Crude Oil975252.07%
Lead203.151.12%
Mentha Oil1093.12.41%
Nickel1858.5142.34%

Currency

USD/INR 95.16(-0.20 %)
GBP/INR 129.27(0.20 %)
EUR/INR 111.65(0.18 %)
JPY/INR 0.61(0.59 %)
CAD/INR 70.13(0.00 %)
HKD/INR 12.16(0.00 %)